Viridian TherapeuticsVRDN
13F holders, Q2 2026 (June 30)214holders −11
44new positions
56sold out
7famous investors
$18.38avg. 13F price*
At the end of Q2 2026, 214 institutions reported holding Viridian Therapeutics Inc. (VRDN) in their 13F filings, down 11 from Q1 2026. 44 opened new positions and 56 sold out. The largest holders were FMR LLC ($305.0M), BlackRock, Inc. ($157.1M) and Bellevue Group AG ($123.7M). 7 famous investors held it, including Steve Cohen (0.1% of Point72 Asset Management's portfolio), Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and David E. Shaw (0.0% of D. E. Shaw & Co.'s portfolio).
- Company
- Viridian Therapeutics Inc.
- CUSIP
- 92790C104
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 44 | $118.4M |
| Exits | 56 | $125.8M |
All 13F filers, Q1 2026 → Q2 2026: 39,206,630 shares bought and 15,547,211 shares sold, net +23,659,419 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 214 holders
| FMR LLC | 0.01% | Add +8.0% | 16,604,740 | $305.0M |
| BlackRock, Inc. | 0.00% | Add +9.2% | 8,551,488 | $157.1M |
| Bellevue Group AG | 2.60% | Add +0.1% | 6,731,909 | $123.7M |
| Paradigm Biocapital Advisors LP | 2.31% | Add +113.5% | 6,723,788 | $123.5M |
| Kynam Capital Management, LP | 6.55% | Add +175.6% | 6,453,877 | $118.6M |
| State Street Corp. | 0.00% | Add +31.1% | 6,124,976 | $112.5M |
| T. Rowe Price Associates Inc. | 0.01% | Add +79.3% | 5,748,410 | $105.6M |
| Fairmount Funds Management LLC | 6.18% | Add +30.1% | 5,090,928 | $93.5M |
| Vanguard Capital Management LLC | 0.00% | Add +9.8% | 4,576,860 | $84.1M |
| Deep Track Capital, LP | 0.97% | Add +157.7% | 3,592,740 | $66.0M |
| Venrock Adviser, LLC | 1.81% | Reduce -16.1% | 3,257,917 | $59.8M |
| Wellington Management Group LLP | 0.01% | Add +1.6% | 3,128,362 | $57.5M |
| Vanguard Portfolio Management LLC | 0.00% | Add +67.7% | 2,752,827 | $50.6M |
| Geode Capital Management, LLC | 0.00% | Add +7.2% | 2,501,869 | $46.0M |
| Avoro Capital Advisors LLC | 0.41% | Add +66.7% | 2,500,000 | $45.9M |
| Baker Bros. Advisors LP | 0.22% | Add +20.9% | 2,383,025 | $43.8M |
| Point72 Asset Management | 0.07% | Add +625.8% | 2,343,208 | $43.0M |
| Caligan Partners LP | 1.94% | New | 2,193,981 | $40.3M |
| Novo Holdings A/S | 2.28% | Add +6.8% | 2,135,000 | $39.2M |
| Tang Capital Management LLC | 1.50% | No change | 1,792,626 | $32.9M |
| Fisher Asset Management | 0.01% | Reduce -1.0% | 1,750,850 | $32.2M |
| Candriam S.C.A. | 0.14% | Add +139.9% | 1,707,698 | $31.3M |
| Goldman Sachs Group Inc. | 0.00% | Add +6.2% | 1,691,304 | $31.1M |
| First Turn Management, LLC | 3.28% | Add +83.3% | 1,670,000 | $30.7M |
| Dimensional Fund Advisors LP | 0.01% | Add +204.2% | 1,611,521 | $29.6M |
| Alliancebernstein L.P. | 0.01% | Reduce -0.0% | 1,391,639 | $27.2M |
| UBS Group AG | 0.00% | Add +365.2% | 1,428,843 | $26.2M |
| Parkman Healthcare Partners LLC | 2.60% | Add +146.9% | 1,377,576 | $25.3M |
| Balyasny Asset Management L.P. | 0.04% | Reduce -44.7% | 1,279,859 | $23.5M |
| D. E. Shaw & Co. | 0.01% | Reduce -6.4% | 1,182,222 | $21.7M |
| Rice Hall James & Associates, LLC | 1.05% | Add +30.9% | 1,175,906 | $21.6M |
| Arrowstreet Capital, Limited Partnership | 0.01% | Add +4678.6% | 1,112,413 | $20.4M |
| BNP Paribas Financial Markets | 0.01% | Add +279.9% | 1,012,138 | $18.6M |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 0.00% | Add +12.6% | 999,915 | $18.4M |
| Elmind Capital, LP | 4.55% | Add +84.1% | 984,931 | $18.1M |
| Bank of America Corp. | 0.00% | Reduce -18.8% | 944,345 | $17.3M |
| Northern Trust Corp. | 0.00% | Add +23.9% | 863,491 | $15.9M |
| Eversept Partners, LP | 0.83% | Add +16.5% | 831,142 | $15.3M |
| Charles Schwab Investment Management Inc. | 0.00% | Add +12.0% | 815,027 | $15.0M |
| Schonfeld Strategic Advisors LLC | 0.08% | New | 793,508 | $14.6M |
| Renaissance Technologies | 0.02% | Add +278.4% | 768,600 | $14.1M |
| Morgan Stanley | 0.00% | Reduce -16.2% | 728,817 | $13.4M |
| Woodline Partners LP | 0.04% | No change | 700,929 | $12.9M |
| JPMorgan Chase & Co. | 0.00% | Reduce -39.6% | 639,929 | $12.1M |
| Vanguard Fiduciary Trust Co. | 0.00% | Add +11.2% | 657,588 | $12.1M |
| Perceptive Advisors LLC | 0.17% | Reduce -50.3% | 581,980 | $10.7M |
| Boothbay Fund Management, LLC | 0.19% | New | 541,058 | $9.9M |
| Emerald Advisers, LLC | 0.23% | New | 537,328 | $9.9M |
| Deutsche Bank AG | 0.00% | Reduce -53.2% | 482,875 | $8.9M |
| Algert Global LLC | 0.11% | Reduce -14.5% | 482,237 | $8.9M |
| Ikarian Capital, LLC | 1.28% | New | 425,000 | $7.8M |
| Yiheng Capital Management, L.P. | 3.24% | Add +91.8% | 400,464 | $7.4M |
| Jump Financial, LLC | 0.07% | Add +521.2% | 398,251 | $7.3M |
| Emerald Mutual Fund Advisers Trust | 0.26% | New | 395,546 | $7.3M |
| Panagora Asset Management Inc. | 0.02% | Add +3.5% | 324,658 | $6.0M |
| XTX Topco Ltd | 0.07% | Add +8.3% | 275,165 | $5.1M |
| Bank of New York Mellon Corp | 0.00% | Add +23.8% | 268,060 | $4.9M |
| Blue Owl Capital Holdings LP | 0.73% | New | 260,000 | $4.8M |
| Affinity Asset Advisors, LLC | 0.23% | No change | 250,000 | $4.6M |
| Voya Investment Management LLC | 0.00% | Reduce -4.7% | 249,763 | $4.6M |
| TD Asset Management Inc | 0.00% | Add +325.4% | 235,606 | $4.3M |
| Hennion & Walsh Asset Management, Inc. | 0.11% | Add +19.6% | 209,092 | $3.8M |
| Nuveen, LLC | 0.00% | Reduce -67.1% | 199,230 | $3.7M |
| Capital Fund Management S.A. | 0.03% | New | 197,848 | $3.6M |
| First Trust Advisors LP | 0.00% | Reduce -39.9% | 181,234 | $3.3M |
| Knott David M Jr | 1.76% | No change | 181,000 | $3.3M |
| Manufacturers Life Insurance Company, The | 0.00% | Add +121.5% | 180,348 | $3.3M |
| Squarepoint Ops LLC | 0.01% | Add +303.0% | 176,955 | $3.3M |
| Privium Fund Management B.V. | 0.59% | No change | 173,516 | $3.2M |
| HighVista Strategies LLC | 0.67% | Add +19.1% | 159,885 | $2.9M |
| Swiss National Bank | 0.00% | Add +20.6% | 155,100 | $2.8M |
| Citigroup Inc. | 0.00% | Add +498.6% | 140,415 | $2.6M |
| F/m Investments LLC | 0.13% | New | 134,761 | $2.5M |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 0.00% | Reduce -4.1% | 134,455 | $2.5M |
| Susquehanna International Group, LLP | 0.00% | Add +140.0% | 130,284 | $2.4M |
| AQR Capital Management | 0.00% | Add +530.0% | 127,301 | $2.3M |
| KVP Capital Advisors, LP | 1.69% | No change | 125,000 | $2.3M |
| Lighthouse Investment Partners, LLC | 0.07% | New | 120,000 | $2.2M |
| Rhumbline Advisers | 0.00% | Add +17.7% | 117,747 | $2.2M |
| Wells Fargo & Company | 0.00% | Add +24.0% | 115,563 | $2.1M |
| Russell Investments Group, Ltd. | 0.00% | Reduce -50.8% | 115,296 | $2.1M |
| Alps Advisors Inc. | 0.01% | New | 111,572 | $2.0M |
| SG Americas Securities, LLC | 0.00% | Add +81.7% | 109,073 | $2.0M |
| Rafferty Asset Management, LLC | 0.00% | Reduce -23.4% | 108,749 | $2.0M |
| J. Safra Sarasin Holding AG | 0.03% | Add +47.6% | 107,839 | $2.0M |
| Jacobs Levy Equity Management, Inc. | 0.01% | New | 101,414 | $1.9M |
| Invesco Ltd. | 0.00% | Reduce -33.9% | 100,895 | $1.9M |
| Diadema Partners LP | 0.69% | New | 100,000 | $1.8M |
| Voleon Capital Management LP | 0.03% | Reduce -63.8% | 97,598 | $1.8M |
| Y-Intercept (Hong Kong) Ltd | 0.04% | New | 96,756 | $1.8M |
| Merck & Co., Inc. | 0.33% | No change | 93,414 | $1.7M |
| Fideuram - Intesa Sanpaolo Private Banking S.P.A. | 0.05% | Add +32.5% | 92,148 | $1.7M |
| California State Teachers Retirement System | 0.00% | Add +12.8% | 91,402 | $1.7M |
| Caption Management, LLC | 0.06% | Add +90.7% | 86,040 | $1.6M |
| Victory Capital Management Inc. | 0.00% | Reduce -56.6% | 81,629 | $1.5M |
| Barclays PLC | 0.00% | Reduce -19.1% | 81,429 | $1.5M |
| Aquatic Capital Management LLC | 0.05% | Add +16.6% | 79,845 | $1.5M |
| Knights of Columbus Asset Advisors LLC | 0.06% | Add +22.1% | 70,553 | $1.3M |
| Burkehill Global Management, LP | 0.04% | No change | 65,000 | $1.2M |
| Legal & General Group Plc | 0.00% | Add +8.7% | 64,788 | $1.2M |
"% of holder's portfolio" is VRDN's weight in each manager's 13F, not the share of Viridian Therapeutics Inc. the manager owns.